(Q35563302)

8 August 2017

1 reference

title

Intraperitoneal chemotherapy with mitoxantrone in malignant ascites (English)

1 reference

8 August 2017

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14567037

22 March 2024

1 reference

https://api.crossref.org/works/10.1016/S1055-3207(03)00050-4

22 March 2024

1 reference

https://api.crossref.org/works/10.1016/S1055-3207(03)00050-4

22 March 2024

author name string

K. H. Link

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14567037

22 March 2024

M. Roitman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14567037

22 March 2024

M. Holtappels

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14567037

22 March 2024

I. Runnebaum

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14567037

22 March 2024

H. Urbanzyk

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14567037

22 March 2024

G. Leder

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14567037

22 March 2024

L. Staib

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14567037

22 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14567037

22 March 2024

publication date

1 July 2003

1 reference

full work available at URL

8 August 2017

https://api.elsevier.com/content/article/PII:S1055320703000504?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S1055-3207(03)00050-4

https://api.elsevier.com/content/article/PII:S1055320703000504?httpAccept=text/plain

22 March 2024

1 reference

https://api.crossref.org/works/10.1016/S1055-3207(03)00050-4

Surgical oncology clinics of North America

22 March 2024

published in

1 reference

8 August 2017

volume

12

1 reference

8 August 2017

issue

3

1 reference

8 August 2017

page(s)

865-72, xvi-xvii

1 reference

In vitro concentration response studies and in vitro phase II tests as the experimental basis for regional chemotherapeutic protocols

8 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900050-4

7 January 2021

Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900050-4

7 January 2021

Cytoreduction and intraperitoneal chemotherapy for the management of peritoneal carcinomatosis, sarcomatosis and mesothelioma.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900050-4

7 January 2021

The role of intraperitoneal chemotherapy in epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900050-4

7 January 2021

Intraperitoneal chemotherapy in ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900050-4

7 January 2021

Phase II trial of weekly or biweekly intraperitoneal mitoxantrone in epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900050-4

7 January 2021

Evidence for persistence of mitoxantrone within the peritoneal cavity following intraperitoneal delivery

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900050-4

7 January 2021

Malignant ascites: review of the literature, and an update on monoclonal antibody-targeted therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900050-4

7 January 2021

Pre-clinical evaluation of the activity of gemcitabine as a basis for regional chemotherapy of pancreatic and colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900050-4

7 January 2021

Intraperitoneal therapy of ovarian cancer

6

1 reference

https://api.crossref.org/works/10.1016/S1055-3207(03)00050-4

In vitro pharmalogic rationale for intraperitoneal regional chemotherapy

22 March 2024

7

1 reference

https://api.crossref.org/works/10.1016/S1055-3207(03)00050-4

Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer

22 March 2024

9

1 reference

https://api.crossref.org/works/10.1016/S1055-3207(03)00050-4

Prospective correlative chemosensitivity testing in high-dose intraarterial chemotherapy for liver metastases

22 March 2024

14

1 reference

https://api.crossref.org/works/10.1016/S1055-3207(03)00050-4

Regional chemotherapy directed by individual chemosensitivity testing in vitro: a prospective decision-aiding trial

22 March 2024

15

1 reference

https://api.crossref.org/works/10.1016/S1055-3207(03)00050-4

Oxaliplatin exerts potent in vitro cytotoxicity in colorectal and pancreatic cancer cell lines and liver metastases

22 March 2024

23

1 reference

https://api.crossref.org/works/10.1016/S1055-3207(03)00050-4

22 March 2024

Identifiers

1 reference

8 August 2017

1 reference